We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+7.11%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$676M
AUM Growth
+$28.8M
Cap. Flow
+$1.28M
Cap. Flow %
0.19%
Top 10 Hldgs %
48.49%
Holding
93
New
3
Increased
59
Reduced
15
Closed
4

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.3M
2
TMDX icon
Transmedics
TMDX
+$6.41M
3
ASML icon
ASML
ASML
+$1.07M
4
CVX icon
Chevron
CVX
+$322K
5
PG icon
Procter & Gamble
PG
+$307K

Sector Composition

Rank Sector Weight
1 Technology 29.83%
2 Healthcare 25.79%
3 Consumer Discretionary 8.29%
4 Financials 7.68%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$121B
$59.3M 8.78%
133,370
+60
+0% +$23.9K
AAPL icon
2
Apple
AAPL
$4.89T
$49.5M 7.33%
234,947
-5,428
-2% -$1.01M
NVDA icon
3
NVIDIA
NVDA
$5.01T
$48.4M 7.16%
391,395
-8,265
-2% -$836K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$3.91T
$33.3M 4.93%
182,786
-2,802
-2% -$472K
MA icon
5
Mastercard
MA
$477B
$32.9M 4.87%
74,635
+549
+0.7% +$250K
AMZN icon
6
Amazon
AMZN
$2.5T
$24.5M 3.63%
126,847
-720
-0.6% -$132K
MSFT icon
7
Microsoft
MSFT
$2.84T
$21.2M 3.14%
47,435
+187
+0.4% +$79K
IDXX icon
8
Idexx Laboratories
IDXX
$42.9B
$20.8M 3.08%
42,742
-257
-0.6% -$129K
ADBE icon
9
Adobe
ADBE
$89.5B
$19.4M 2.87%
34,932
-36
-0.1% -$17.4K
JPM icon
10
JPMorgan Chase
JPM
$939B
$18.2M 2.7%
90,223
+690
+0.8% +$135K
LLY icon
11
Eli Lilly
LLY
$1.07T
$16M 2.37%
17,715
+315
+2% +$252K
XOM icon
12
ExxonMobil
XOM
$651B
$15.8M 2.34%
137,083
+1,347
+1% +$157K
LOW icon
13
Lowe's Companies
LOW
$116B
$13.6M 2.01%
61,535
+1,132
+2% +$258K
ABBV icon
14
AbbVie
ABBV
$458B
$13.3M 1.97%
77,556
+1,488
+2% +$246K
COST icon
15
Costco
COST
$415B
$12.8M 1.89%
15,037
+389
+3% +$304K
PG icon
16
Procter & Gamble
PG
$343B
$12.5M 1.86%
76,025
+1,880
+3% +$307K
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$121B
$11.5M 1.7%
24,430
+23,765
+3,574% +$10.3M
NOW icon
18
ServiceNow
NOW
$102B
$10.5M 1.55%
66,620
+400
+0.6% +$58.7K
CVX icon
19
Chevron
CVX
$388B
$10.4M 1.54%
66,578
+2,020
+3% +$322K
SO icon
20
Southern Company
SO
$110B
$10.2M 1.51%
131,660
+3,841
+3% +$291K
SPG icon
21
Simon Property Group
SPG
$74.5B
$10.1M 1.5%
66,668
+1,855
+3% +$273K
MCD icon
22
McDonald's
MCD
$188B
$10.1M 1.49%
39,614
+1,103
+3% +$293K
AMGN icon
23
Amgen
AMGN
$203B
$10.1M 1.49%
32,255
+912
+3% +$268K
LMT icon
24
Lockheed Martin
LMT
$134B
$9.92M 1.47%
21,227
+600
+3% +$277K
XYZ
25
Block Inc
XYZ
$45.9B
$9.39M 1.39%
145,569
+1,795
+1% +$126K

Similar funds

Biondo Investment Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Biondo Investment Advisors held 93 positions worth $676M, up 4.5% from $647M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Biondo Investment Advisors's Q2 2024 filing shows 3 new, 59 increased, 15 reduced and 4 closed positions. Its largest new stake was Transmedics: 53,405 shares worth $8.04M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Biondo Investment Advisors's largest Q2 2024 buy was Transmedics: 53,405 shares worth $8.04M.
  • Biondo Investment Advisors added most to Vertex Pharmaceuticals in Q2 2024, an estimated $10.3M increase.
  • Biondo Investment Advisors's biggest Q2 2024 reduction was Apple, cutting an estimated $1.01M.
  • Biondo Investment Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $12.7M.
  • Biondo Investment Advisors's ten largest holdings make up 48% of its $676M portfolio in Q2 2024.
  • Biondo Investment Advisors opened 3 new positions and closed 4 in Q2 2024.
  • Biondo Investment Advisors's portfolio value rose 4.5% quarter-over-quarter to $676M.

Based on Biondo Investment Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.